Clinical Lymphoma, Myeloma and Leukemia

eISSN: 2152-2669pISSN: 2152-2650

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
3.6
H-Index
60
SJR
Q2Oncology
SNIP
0.78
2
Time to Publish
time-to-publish View Chart
2  Mo

Journal Specifications

Overview
  • Publisher
    CIG MEDIA GROUP, LP
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 76%
4-6 21%
7-9 2%
>9 1%

Recently Published Papers

Year-wise Publication

FAQs

Since when has Clinical Lymphoma, Myeloma and Leukemia been publishing? Faqs

The Clinical Lymphoma, Myeloma and Leukemia has been publishing since 2010 till date.

How frequently is the Clinical Lymphoma, Myeloma and Leukemia published? Faqs

Clinical Lymphoma, Myeloma and Leukemia is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Clinical Lymphoma, Myeloma and Leukemia? Faqs

Clinical Lymphoma, Myeloma and Leukemia has a H-index score of 60, Citescore of 3.6, SNIP score of 0.78, & SJR of Q2

Who is the publisher of Clinical Lymphoma, Myeloma and Leukemia? Faqs

The publisher of Clinical Lymphoma, Myeloma and Leukemia is CIG MEDIA GROUP, LP.

How can I view the journal metrics of Clinical Lymphoma, Myeloma and Leukemia on editage? Faqs

For the Clinical Lymphoma, Myeloma and Leukemia metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Clinical Lymphoma, Myeloma and Leukemia? Faqs

The eISSN number is 2152-2669 and pISSN number is 2152-2650 for Clinical Lymphoma, Myeloma and Leukemia.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.